FAQ
Log In
Friday 9th December 2016
News
 › 
 › 

Flu vaccine development

4th May 2006

The U.S. Health and Human Services Department have awarded five companies, including GlaxoSmithKline, more than $1 billion (540 million pounds) in contracts to develop new and better influenza vaccines.

The companies will all work to develop cell based-vaccines to fight influenza; GlaxoSmithKline was awarded $274.75 million (148.60 million pounds), MedImmune was awarded $169.46 million, Novartis AG won $220.51 million, DynPort vaccine, working with Baxter International Inc. , won $40.97 million and Solvay won $298.59 million.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Flu vaccine development
Author: Sue Knights
Article Id: 273
Date Added: 4th May 2006

Sources

News Now

Recent Related Articles

France placed on 'high risk' over bird flu

Oral vaccine against Zika to be produced

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016